- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01813747
Mandible and Sub-mandible Using the 1440nm Wavelength Laser and Hand Piece
October 26, 2020 updated by: Cynosure, Inc.
The purpose of this study is to use the 1440nm Wavelength laser along with the hand piece to provide clinical outcome data for treatment of the mandibular and submandibular areas specifically for skin tightening and laser lipolysis.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Greenvale, New York, United States, 11548
- Cosmetique - Dermatology, Laser & Plastic Surgery LLP
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy non-smoking male or female subjects 18-65 years of age
- Presents for treatment of their unwanted skin laxity and fat in the mandibular and submandibular areas for an improved aesthetic appearance and is willing to undergo laser treatment
- Understands/accepts obligation not to receive any other procedures in the mid-face to sub-mandibular areas through 3 months follow up visit
- Understands/accepts the obligation and is logistically able to present for all scheduled follow up visits
- Is capable of understanding the consent form and able to provide written consent to participate in the study and any other practice consents for anesthesia and surgical procedures
- Understands/accepts obligation to have facial photographs taken
- Understands/accepts may be asked to consent to having a two 2mm biopsies in an inconspicuous place such as behind the ear
- Agrees to maintain present diet and exercise program
Exclusion Criteria:
- Has had any procedure in the mid-face to sub-mandibular areas in the last six months
- Has a history of thrombophlebitis, history of coagulation disorders or using anticoagulant medications
- Has a significant systemic illness or immunity disorder or localized condition affecting treatment area
- Is female and pregnant, was pregnant or given birth within the last three months, is currently breast feeding, or planning a pregnancy during the course of the study
- Has known history of allergic reactions to local anesthesia
- Has any other medical condition, that, in the investigator's opinion would interfere with the subject's participation in the study
- Is susceptible to light induced seizures or history of seizures
- Has a history of keloid formation
- Has therapies or medications which may interfere with the treatment (including medications causing photosensitivity
- Has a BMI above 30
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1440 nm wavelength laser with hand piece
To assess the effectiveness of the 1440 nm wavelength laser with handpiece for skin tightening and laser lipolysis for the mandibular and sub-mandibular areas
|
To assess the effectiveness of device in skin tightening and laser lipolysis in the mandibular and sub-mandibular areas.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Photographic Evaluation
Time Frame: 3 months post last treatment
|
Photos will be evaluated by the investigator comparing time baseline and 3 month photos using the global aesthetic improvement scale
|
3 months post last treatment
|
Photographic Evaluation
Time Frame: 3 months post last treatment
|
Photographs will be evaluated and compared by investigator for baseline and 3 month images using the Cervicomental Angle Scale
|
3 months post last treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with adverse events
Time Frame: up to 3 months post last treatment
|
Side effects and events will be recorded
|
up to 3 months post last treatment
|
Photographic Evaluation
Time Frame: 1 week post treatment
|
Photos will be evaluated by the investigator comparing time baseline and 1 week photos using the global aesthetic improvement scale
|
1 week post treatment
|
Photographic Evaluation
Time Frame: 1 week post treatment
|
Photographs will be evaluated and compared by investigator for baseline and 1 week images using the Cervicomental Angle Scale
|
1 week post treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (Actual)
August 1, 2013
Study Completion (Actual)
August 1, 2013
Study Registration Dates
First Submitted
March 12, 2013
First Submitted That Met QC Criteria
March 15, 2013
First Posted (Estimate)
March 19, 2013
Study Record Updates
Last Update Posted (Actual)
October 27, 2020
Last Update Submitted That Met QC Criteria
October 26, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- CYN10-DS-MS2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Tightening of the Mandibular and Sub-mandibular Areas
-
Cairo UniversityCompletedThe Prevalence of Bifid Mandibular CanalEgypt
-
University Hospital, MontpellierCompletedMandibular Asymmetry | Functional Shift of the MandibleFrance
-
Assistance Publique - Hôpitaux de ParisRecruitingIntra-articular Fracture of the Mandibular CondyleFrance
-
Taibah UniversityCompletedOvercoming the Failure of Anesthesia in the Mandibular TeethSaudi Arabia
-
Damascus UniversityCompletedCrowding of Anterior Mandibular TeethSyrian Arab Republic
-
University of the Basque Country (UPV/EHU)UnknownPain | Mandibular Range of Motion | Sensorial DisturbanceSpain
-
AZ Sint-Jan AVRecruitingQuality of Life | Mandibular Reconstruction | Benign or Malignant Tumour of the Oral Cavity | Stage III-IV Osteonecrosis | Fixed Dental RestorationBelgium
-
Damascus UniversityCompletedCrowding of Anterior Mandibular TeethSyrian Arab Republic
-
Sara ZayedActive, not recruitingAtrophy of Edentulous Mandibular Alveolar RidgeEgypt
-
AO Innovation Translation CenterRecruitingMandibular Reconstruction | Segmental Mandibular DefectsGermany, Switzerland, United States, Netherlands, Sweden, Spain
Clinical Trials on 1440 nm wavelength laser with handpiece (Cynosure)
-
Cynosure, Inc.CompletedHyperhidrosisUnited States
-
Alexandria UniversityCompletedDentin HypersensitivityEgypt
-
Second Affiliated Hospital, School of Medicine,...CompletedAcne | Atrophic ScarChina
-
Cynosure, Inc.Completed
-
Cairo UniversityUnknownCleft Palate Children | Laser
-
Ospedale San RaffaeleCompletedAge-Related Macular Degeneration | Geographic Atrophy | Reticular PseudodrusenItaly
-
Al-Azhar UniversityCompletedStomatitis (Oral Mucositis)Egypt
-
University of MichiganCompleted
-
Centre hospitalier de l'Université de Montréal...RecruitingCataract | Astigmatism | Corneal Endothelial Cell LossCanada
-
Trakya UniversityCompletedFrenulum; Hypertrophy